Tofacitinib Tablet, Film Coated
FDA Label NDC 70771-1821

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Tofacitinib (NDC 70771-1821). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Tofacitinib Tablets, 5 mg

NDC 70771-1821-6

60 Tablets

Rx only

5 mg Label (F649d98f 1346 4ead 8c8f 2d2dc41949a2 01)

5 mg Label (F649d98f 1346 4ead 8c8f 2d2dc41949a2 01)

* Please review the disclaimer below.